Compound Detail
CHEMBL4439321
ATUVECICLIB Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL4439321 |
| Name | ATUVECICLIB |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | ACWKGTGIJRCOOM-HHHXNRCGSA-N |
40
Targets
67
Activities
1
Assay Types
1
PK Parameters
20
Publications
1
Known Names
1
Indications
Molecular Properties
387.4
MW (Da)
3.61
ALogP
7
HBA
2
HBD
100.8
PSA (Ų)
0.67
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Leukemia
Activity Summary
IC50 67 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 8.3 | 7.8527 | 5.0 | 11 |
| Cyclin-dependent kinase 9 CHEMBL3116 | IC50 | 8.22 | 7.016 | 6.0 | 5 |
| Unchecked CHEMBL612545 | IC50 | 7.89 | 6.575 | 13.0 | 8 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | IC50 | 7.35 | 7.35 | 45.0 | 2 |
| Glycogen synthase kinase-3 beta CHEMBL262 | IC50 | 7.06 | 7.06 | 87.0 | 2 |
| PANC-1 CHEMBL614139 | IC50 | 6.96 | 6.96 | 110.0 | 1 |
| CDK9/Cyclin K CHEMBL3038475 | IC50 | 6.82 | 6.82 | 150.0 | 1 |
| MOLM-13 CHEMBL3706572 | IC50 | 6.7 | 6.605 | 200.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 6.58 | 6.055 | 260.0 | 2 |
| A-431 CHEMBL614069 | IC50 | 6.47 | 6.47 | 340.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 6.33 | 6.165 | 470.0 | 2 |
| MV4-11 CHEMBL613835 | IC50 | 6.25 | 6.25 | 560.0 | 1 |
| MDA-MB-436 CHEMBL4296465 | IC50 | 6.2 | 6.2 | 630.0 | 1 |
| NCI-H1975 CHEMBL614348 | IC50 | 6.14 | 6.14 | 720.0 | 1 |
| CDK3/cyclin E CHEMBL2111444 | IC50 | 6.05 | 6.05 | 890.0 | 1 |
| Cyclin-dependent kinase 2/cyclin A CHEMBL2094128 | IC50 | 6.01 | 6.01 | 975.2 | 1 |
| Cyclin-dependent kinase 2/cyclin E CHEMBL2094126 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 6.0 | 5.98 | 1000.0 | 2 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.88 | 5.88 | 1320.0 | 1 |
| Tyrosine-protein kinase Yes CHEMBL2073 | IC50 | 5.83 | 5.83 | 1495.0 | 1 |
| B16 CHEMBL381 | IC50 | 5.83 | 5.83 | 1470.0 | 1 |
| HeLa CHEMBL399 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta CHEMBL4121 | IC50 | 5.78 | 5.78 | 1650.0 | 1 |
| Ephrin type-A receptor 1 CHEMBL5810 | IC50 | 5.76 | 5.76 | 1737.0 | 1 |
| BT-549 CHEMBL614072 | IC50 | 5.7 | 5.7 | 2010.0 | 1 |
| Ephrin type-B receptor 1 CHEMBL5072 | IC50 | 5.69 | 5.69 | 2032.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma CHEMBL3829 | IC50 | 5.68 | 5.68 | 2081.0 | 1 |
| L02 CHEMBL4296457 | IC50 | 5.59 | 5.59 | 2550.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
| Tyrosine-protein kinase ABL2 CHEMBL4014 | IC50 | 5.55 | 5.55 | 2843.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 9 CHEMBL2872 | IC50 | 5.52 | 5.52 | 3010.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta CHEMBL2801 | IC50 | 5.48 | 5.48 | 3340.0 | 1 |
| A549 CHEMBL392 | IC50 | 5.48 | 5.48 | 3290.0 | 1 |
| Tyrosine-protein kinase Lyn CHEMBL3905 | IC50 | 5.45 | 5.45 | 3514.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 5.28 | 5.28 | 5293.0 | 1 |
| Interleukin-1 receptor-associated kinase 1 CHEMBL3357 | IC50 | 5.26 | 5.26 | 5454.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 5.26 | 5.26 | 5520.0 | 1 |
| Tyrosine-protein kinase Fgr CHEMBL4454 | IC50 | 5.11 | 5.11 | 7754.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 54.0 | % | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37870244 | 10.1021/acs.jmedchem.3c01400 | Unchecked | 11 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 9 |
| - | 10.6019/CHEMBL5303304 | U2OS | 9 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 8 |
| 33338869 | 10.1016/j.ejmech.2020.113091 | MV4-11 | 6 |
| - | 10.6019/CHEMBL5465560 | Cyclin-dependent kinase 5/CDK5 activator 1 | 3 |
| - | 10.6019/CHEMBL5465560 | Cyclin-dependent kinase 2/cyclin E | 3 |
| - | 10.6019/CHEMBL5465560 | CDK3/cyclin E | 3 |
| - | 10.6019/CHEMBL5465560 | Calcium/calmodulin-dependent protein kinase type II subunit delta | 2 |
| - | 10.6019/CHEMBL5465560 | CDK1/Cyclin E | 2 |
| - | 10.6019/CHEMBL5465560 | CDK9/Cyclin K | 2 |
| - | 10.6019/CHEMBL5465560 | Glycogen synthase kinase-3 alpha | 2 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | Unchecked | 2 |
| - | 10.6019/CHEMBL5444388 | Cyclin-dependent kinase 9 | 2 |
| 31477350 | 10.1016/j.bmcl.2019.126637 | CDK9/cyclin T1 | 2 |
| 33338869 | 10.1016/j.ejmech.2020.113091 | Protein cereblon/CDK9 | 2 |
| - | 10.6019/CHEMBL5465560 | Calcium/calmodulin-dependent protein kinase type II subunit gamma | 2 |
| - | 10.6019/CHEMBL5465560 | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2 |
| - | 10.6019/CHEMBL5465560 | Glycogen synthase kinase-3 beta | 2 |
| 32787081 | 10.1021/acs.jmedchem.0c00962 | Cyclin-dependent kinase 9 | 2 |
Data from ChEMBL 36 via Core Engine